Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colonoscopic Spray vs Oral Probiotics for IBS
NCT05864716Not yet recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, double-blind trial of SynPro-15G in irritable bowel syndrome (IBS) (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Change in the IBS Severity Scoring System total score at 84 days. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
SynPro-15G
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05864716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864716.